April 5, 2013 12:10 PM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
In a report published Friday, Goldman Sachs analyst Matthew J. Fassler reiterated a Neutral rating on Rite Aid Corporation (NYSE: RAD), but slightly lowered the price target from $1.85 to $1.75.In the report, Fassler noted, “RAD reported March sales including pharmacy volume that were a tad light, partially offset by better front-end trends, on the shift of Easter selling days into March and some underlying improvement. Slower prescription growth was inevitable – and widely understood – on tougher compares associated with cycling the capture of WAG/ESRX customers a year ago, though the degree of slowing in same-store script volumes still surprised us to the downside. Year ago compares become significantly tougher in April, and more challenging still in the summer months, peaking in October. As such, we believe the set-up for RAD over the balance of this year is difficult.”Rite Aid Corporation closed on Thursday at $1.72.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.